非酒精性脂肪肝的机制和疾病后果
Rohit Loomba1, Scott L Friedman2, Gerald I Shulman3
1NAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
非酒精性脂肪性肝病 (NAFLD) 进展为非酒精性脂肪性肝炎 (NASH),导致肝损伤. 这篇评论详细介绍了NASH机制,包括代谢功能障碍和遗传因素,导致纤维化和癌症风险.
科学领域:
- 肝病和代谢疾病
- 胃肠病学研究
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是一个全球性的健康问题.
- 非酒精性脂肪肝炎 (NASH) 是一种严重的NAFLD亚型,导致肝硬化和癌症.
研究的目的:
- 综合审查NASH中进展性肝损伤的病原机制.
- 探索代谢,遗传,表观遗传和环境因素对NASH进展的影响.
主要方法:
- 关于NAFLD和NASH病变的深入文献审查和综合研究.
- 讨论肝损伤和纤维化的关键分子和细胞途径.
主要成果:
- NAFLD是由影响肝脏葡萄糖和脂质代谢的代谢失调引起的.
- 胆酸毒性,巨细胞功能障碍和肝星细胞激活导致肝损伤.
- 遗传,表观遗传和环境因素加剧了NASH中的纤维化和肝细胞癌风险.
结论:
- 了解这些复杂的机制对于开发针对性治疗NASH至关重要.
- 识别纤维化和癌症风险的主要驱动因素可以为预防策略和治疗方法提供信息.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Coronary Artery Disease II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Atherosclerosis I: Introduction
